| | Surgical complications of pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy☆Presented at the 49th Annual Congress of the British Association of Paediatric Surgeons, Cambridge, England, July 23-26, 2002. Abstract Purpose: The aim of this study was to review the surgical complications of pancreatectomy for persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI). Methods: A retrospective review was conducted of patients undergoing pancreatectomy for PHHI in one institution over the past 13 years. Results: The records of 48 patients were reviewed; the age at operation ranged from 10 days to 30 months (median, 8 weeks). Weight at operation ranged from 1.97 to 11.4 kg (median, 5.2 kg). There were no deaths. Intraoperative complications comprised bleeding in 7, (major in 2), splenic injury in one, bile duct injury in 2 (1 oversewn, 1 choledochoduodenostomy), and 1 small bowel injury. Postoperatively, 5 children underwent choledochoduodenostomy: 2 for biliary leak and 3 for delayed bile duct stricture. Other postoperative complications included wound infection (n = 3), prolonged ileus (n = 1) and adhesion obstruction (n = 1), and wound leakage (n = 1). Renal failure developed in one child owing to acute tubular necrosis. Nine patients required further pancreatic resection because of continued hypoglycaemia. Three patients continued to require medication for hyperinsulinism despite surgery, 20 required insulin, and 13 required pancreatic enzyme replacement at the time of the last review. Conclusions: Pancreatectomy resulted in resolution of hyperinsulinism in 45 of 48 patients. Sixteen patients required no further surgery or medication. Pancreatectomy for PHHI may be associated with major intra and postoperative morbidity. J Pediatr Surg 38:13-16. Copyright 2003, Elsevier Science (USA). All rights reserved.
Persistent hyperinsulinaemic hypoglycaemia of infancy (PHHI) is a rare disorder with an estimated incidence of 1,50,000.1 Untreated or undertreated PHHI leads to almost certain neurologic impairment and often death.2, 3, 4 Historically, over half of the infants surviving treatment for PHHI had neurologic impairment, with increased age at surgery being associated with an increased incidence in neurologic damage and even those who appear intact have been shown to have impaired head growth.2, 3, 4 This has led to more aggressive management with earlier progress to pancreatic resection.
The surgical techniques used have been refined such that splenic conservation is routine, eliminating the problem of postsplenectomy sepsis.3, 5, 6 The extent of resection remains controversial.3, 7, 8, 9, 10
Materials and methods  A retrospective review was carried out of the surgical complications in patients undergoing subtotal pancreatectomy for PHHI by the senior author over the 13-year period (1990 through 2002). Fifty-four patients were identified with records available in 48. The operative technique has been described previously, with the exception that diathermy coagulation rather than suture ligation of the pancreatic vessels now is performed.2
Results  The age at operation ranged from 10 days to 30 months (median, 8 weeks). Weight at operation ranged from 1.97 to 11.4 kg (median, 5.2 kg). The smallest infant, born at 33 weeks, was operated on at 7 weeks of age. There were no deaths. Intraoperative complications comprised bleeding in 7, which was severe in 2: one from the splenic vein the other from the portal vein, both of which were repaired (Table 1).
 | Intraoperative | |  |
 | Haemorrhage | 7 |  |
 | Splenic injury | 1 |  |
 | Small intestinal injury | 1 |  |
 | Bile duct injury | 2 |  |
 | Postoperative | |  |
 | Bile leak | 2 |  |
 | Bile duct stricture | 3 |  |
 | Wound infection | 3 |  |
 | Ileus | 1 |  |
 | Wound leakage | 1 |  |
 | Adhesion obstruction | 1 |  | | | |
The smallest infant in the group suffered injury to the splenic vein and spleen, requiring ligation of the splenic vein but with conservation of the spleen. A small bowel injury was oversewn. Bile duct injury occurred in 7 patients and was related directly to the extent of the pancreatic resection. None of the 6 infants undergoing a subtotal pancreatectomy (<80%) sustained an injury to the bile duct. Five bile duct injuries were encountered among 42 patients undergoing “95%” pancreatectomy as the primary procedure (11.9%), whereas 2 bile ducts were damaged in the 9 infants undergoing redo or extended pancreatectomy after initial subtotal resection (22.2%). Two of the injuries to the bile duct were recognised intraoperatively; in one the duct was repaired, in the other, an end-to-side choledochoduodenostomy was performed. Five children underwent later choledochoduodenostomy, 2 for biliary leak and 3 for delayed bile duct stricture. Of these 3, one had a subsequent bile leak that was managed by percutaneous drainage and another later had portal fibrosis. Other postoperative complications included wound infection in 3, prolonged ileus in one, serous wound leakage in one, and adhesion obstruction in one. One child had renal failure caused by acute tubular necrosis. Histopathologic examination of resected specimens identified focal lesions in 15 patients, 9 of whom had undergone a curative 95% resection. A focal lesion was diagnosed intraoperatively in 6 patients (5 on frozen section); all underwent resection of the body and tall of the pancreas. Three of these required a second resection for lesions in the pancreatic head. Six of 33 patients with diffuse disease required a second resection, one of whom still requires medical treatment for hypoglycaemia, consent having been refused for a third resection. Two further patients with diffuse disease continue to require medication for hyperinsulinism. Twenty patients required insulin, and 13 required pancreatic enzyme replacement at the time of last review (Fig 1).
Discussion  Hypoglycaemia with hyperinsulism in infancy frequently is transient: the majority of cases can be managed medically without resorting to surgery.11, 12 During the period of stabilisation and diagnosis secure venous access is essential. These6 infants usually are obese, making peripheral cannulation difficult. Early central venous catheter insertion will allow continuous controlled administration of glucose, reducing the risk of hypoglycaemia and subsequent brain damage as well as providing access for repeat blood sampling. Initial medical management includes increasing the carbohydrate intake, accompanied by medication to reduce insulin secretion and promote glycogen mobilisation; these include diazoxide, chlorothiazide, octreotide, and glucagon.13 Once the diagnosis has been established, infants with PHHI that cannot be controlled safely with frequent feeding and oral medication should undergo elective partial pancreatectomy as soon as possible. The extent of pancreatectomy remains controversial. Inadequate resection will result in continued hyperinsulinism, whereas near-total pancreatectomy will result in almost all patients eventually requiring insulin therapy.8 Differentiation of focal from diffuse disease may allow for more limited resection in approximately one third of patients whose disease is focal.7 Pancreatic venous sampling (PVS) and intraarterial calcium stimulation tests are used to identify and localise focal disease. Our initial experience with these techniques have been disappointing with less than 50% successful diagnosis of focal disease. This compares with published results of 60% to 80% of focal cases correctly identified by PVS.10, 14 Intraoperative biopsy and frozen section are used in conjunction with PVS to identify focal lesions. A biopsy showing normal pancreatic tissue promotes exploration for a focal abnormality. In our experience, focal lesions are not identified easily macroscopically, and patients with suspected focal disease underwent 70% to 80% distal pancreatectomy at the initial operation. Focal lesions were present in 15 patients, 9 had undergone 95% resection (8 before the practice of frozen section assessment). Six underwent limited pancreatic resection, 3 of whom required a second resection for lesions in the pancreatic head. Thus, correct pre- or intraoperative localisation of the lesion may have permitted more limited resection in 4 of our 48 patients. Haemorrhage is a major risk in pancreatic resection because of the rich vascular supply and the close proximity of the pancreas to the splenic and portal vein and superior mesenteric vessels. This complication is not reported elsewhere, although this may be because of underreporting of a complication common to many surgical procedures. Some investigators do report splenic conservation despite ligation of the splenic vein, presumably to control bleeding.3, 5, 15 In most cases, bleeding from the splenic vein can be controlled by direct suture while maintaining the venous blood flow from the spleen. Intraoperative bile duct injury and late bile duct strictures presumed secondary to ischaemia are reported in most of the large series.7, 8, 16 Ninety-five percent or greater resection requires resection of pancreatic tissue in close proximity to the common bile duct and adjacent to the duodenum. Technically, this is the most difficult part of the resection, and positive identification of the bile duct before dissection combined with a careful search for injury after dissection are essential. Long-term follow up data have shown that almost all children undergoing subtotal pancreatectomy eventually will need insulin replacement therapy.8 We anticipate that with longer follow-up the number of patients in our series requiring insulin therapy will increase. We also expect pancreatic exocrine deficiency to develop particularly in children undergoing near-total resection and, thus, actively investigate these children for pancreatic enzyme deficiency. Partial pancreatectomy brought about resolution of hyperinsulinism in 44 of 48 patients. However, only 16 patients required no further surgery or medication. Thus, although pancreatectomy for PHHI, successfully controlled hyperinsulinism in most of the infants, it was associated with major intra- and postoperative morbidity in over half. Pancreatic resection currently is the only option for patients with PHHI. However, the risk of surgical complications combined with the likelihood of pancreatic insufficiency mean that this answer to the problem of hypersecretion of insulin is far from satisfactory.
Discussion  S. Langer (Toronto, Ontario): You did not tell us what your follow-up was, and in the Toronto experience, we found that a great many of these patients went on to have diabetes and were insulin dependent, and I suspect that maybe 20 might become much bigger. The second thing is that we have actually become more conservative in how much pancreas we take, which I think lowers the operative morbidity, and with the use of octreotide, those patients can be treated with much less pancreatic resection. I would like to know what your follow-up there has been and what use of octreotide was made in your study? H.F. McAndrew (response): I have commented on the fact that I think with longer follow-up there will be more patients requiring insulin. Unfortunately, quite a large group of our patients are overseas and to actually follow up with retrospectively is very difficult, so that some of the follow-up is very short. Some of the UK patients have been followed up for 8 to 10 years. I did not specifically mention octreotide in the report because I concentrated on the surgical rather than medical management, certainly it is commonly used in the patients later in the series. A. Beersheva (Mares, Israel): I understand that this report is based on work over 40 years. I wonder how long have they been kept on medical treatment, on octreotide, and what caused them to be brought for surgery? H.F. McAndrew (response): This series was over 13 years, although the data have been published previously of patients before that time. The patients are treated medically before referral by the paediatric endocrinologists. There is a fairly high proportion of patients with a family history of hyperinsulinism, and they come much more quickly to surgery. In the other patients, it is a decision made jointly by the Professor and the paediatric endocrinologists as to when medical treatment is failing. J. Grosfeld (Indianapolis, IN): Why did you choose to do a choledochoduodenostomy in the paediatric age group rather than a choledochojejunostomy, because we know that the former operation over the lifetime of the patient is prone to be associated with other complications when they get older. I think most surgeons would not use a choledochoduodenostomy in patients who have a long lifespan ahead of them. Is there a particular reason that operation was chosen as the method of repair for the complication? H.F. McAndrew (response): In partial pancreatectomy, the injury to the bile duct is low and close to the duodenum and it lends itself more easily to choledochoduodenostomy. Certainly, in the follow-up there have been no long-term complications, but follow-up is a maximum of 13 years. References  1.
1
Dunne MJ, Kane C, Shepherd RM, et al.
Familial persistent hyperinsulinaemic hypoglycaemia of infancy and mutations in the sulphonylurea receptor.
N Engl J Med. 1997;336:703–706. MEDLINE |
CrossRef
2.
2
Spitz I, Bhargava RK, Grant DB, et al.
Surgical treatment of hyperinsulinaemic hypoglycaemia in infancy and childhood.
Arch Dis Child. 1992;67:201–205.
CrossRef
3.
3
Thomas CG, Underwood LE, Carney CN, et al.
Neonatal and infantile hypoglycaemia due to insulin excess: New aspects of diagnosis and surgical management.
Ann Surg. 1977;185:505–517. MEDLINE 4.
4
Jacobs D, Haka-Ikse K, Wesson D, et al.
Growth and development of patients operated on for islet cell dysplasia.
J Pediatr Surg. 1984;21:1184–1189. Abstract |
CrossRef
5.
5
Martin LW, Ryckman FC, Sheldon CA.
Experience with 95% pancreatectomy and splenic salvage for neonatal nesidioblastosis.
Ann Surg. 1984;200:355–362. MEDLINE 6.
6
Knight J, Garvin PJ, Danis RK, et al.
Nesidioblastosis in children.
Arch Surg. 1980;115:880–882. MEDLINE 7.
7
Cretolle C, Fekete CN, Nassogne J, et al.
Partial elective pancreatectomy is curative in focal form of permentant hyperinsulemic hypoglycaemia in infancy: A report of 45 cases from 1983-2000.
J Pediatr Surg. 2002;37:155–158. Abstract | Full Text |
Full-Text PDF (34 KB)
|
CrossRef
8.
8
Shiylansky J, Fisher S, Cutze , et al.
Is 95% pancreatectomy the procedure of choice for the treatment of persistent hyperinsulinaemic hypoglycaemia of the neonate.
J Pediatr Surg. 1997;32:342–346. Abstract |
Full-Text PDF (532 KB)
|
CrossRef
9.
9
Parashar K, Upadhyay V, Corkery JJ.
Partial or near total pancreatectomy for Nesidioblastosis?.
Eur J Pediatr Surg. 1995;5:146–148. MEDLINE |
CrossRef
10.
10
Lonay-Debeney P, Poggi-Travert F, Fournet J-C, et al.
Clinical features of 52 neonates with hyperinsulinism.
N Engl J Med. 1999;340:1164–1175. 11.
11
Ansley-Green A.
Hypoglycaemia in infants and children.
Clin Endocrin Metab. 1982;11:189–194. 12.
12
Gough MH.
The surgical treatment of hyperinsulism in infancy and childhood.
Br J Surg. 1984;71:75–78. MEDLINE |
CrossRef
13.
13
Glaser B, Hirsch HJ, Landau H.
Persistent hyperinsulinaemic hypoglycaemia of infancy: Long-term octreotide treatment without pancreatectomy.
J Pediatr. 1993;123:644–650. Abstract |
Full-Text PDF (628 KB)
|
CrossRef
14.
14
Dubois J, Brunelle F, Touati G, et al.
Hyperinsulism in children: Diagnostic value of pancreatic venous sampling correlated with clinical, pathological and surgical outcome in 25 cases.
Pediatr Radiol. 1995;25:512–516. MEDLINE |
CrossRef
15.
15
Willberg B, Muller E.
Surgery for Nesidioblastosis.
Prog Paediatr Surg. 1991;26:76–83. 16.
16
Filler RM, Weinberg MJ, Cutz E, et al.
Current status of pancreatectomy for persistent idiopathic neonatal hypoglycaemia due to islet cell dysplasia.
Prog Paediatr Surg. 1991;26:60–75. Departments of Surgery and Pathology, Great Ormond Street Hospital for Children, London, England ☆ Address reprint requests to Miss H.F. McAndrew, MD FRCS(Paed Surg), Department of Surgery, Great Ormond Street Hospital for Children, Great Ormond St, London, England, WC1N 3JH. PII: S0022-3468(02)63009-X doi:10.1053/jpsu.2003.50001 © 2003 Published by Elsevier Inc. | |
|